Glen Harbor Capital Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Glen Harbor Capital Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-13,580	Closed	-$732K	–	1315
2017 Q4	$732K	Buy	13,580 +2,912	+27%	+$159K	0.02%	520
2017 Q3	$609K	Sell	10,668 -3,220	-23%	-$189K	0.01%	538
2017 Q2	$836K	Buy	13,888 +8,680	+167%	+$494K	0.02%	457
2017 Q1	$284K	Buy	+5,208	New	+$257K	0.01%	676

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Glen Harbor Capital Management's BIVV Position: Q1 2018 in Review

Glen Harbor Capital Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 13,580 shares — an estimated $732K sold.

Glen Harbor Capital Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $836K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Glen Harbor Capital Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Glen Harbor Capital Management sold 13,580 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $732K.
Glen Harbor Capital Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Glen Harbor Capital Management's Bioverativ Inc. Common Stock position peaked at $836K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Glen Harbor Capital Management's 13F filing for Q1 2018, filed 9 May 2018.